These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 33390681)
1. Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (M Mohapatra RK; Perekhoda L; Azam M; Suleiman M; Sarangi AK; Semenets A; Pintilie L; Al-Resayes SI J King Saud Univ Sci; 2021 Mar; 33(2):101315. PubMed ID: 33390681 [TBL] [Abstract][Full Text] [Related]
2. Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations. Amin MR; Yasmin F; Dey S; Mahmud S; Saleh MA; Emran TB; Hasan I; Rajia S; Ogawa Y; Fujii Y; Yamada M; Ozeki Y; Kawsar SMA Glycoconj J; 2022 Apr; 39(2):261-290. PubMed ID: 35037163 [TBL] [Abstract][Full Text] [Related]
3. Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19. Rai H; Barik A; Singh YP; Suresh A; Singh L; Singh G; Nayak UY; Dubey VK; Modi G Mol Divers; 2021 Aug; 25(3):1905-1927. PubMed ID: 33582935 [TBL] [Abstract][Full Text] [Related]
4. Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and Mohapatra RK; Dhama K; El-Arabey AA; Sarangi AK; Tiwari R; Emran TB; Azam M; Al-Resayes SI; Raval MK; Seidel V; Abdalla M J King Saud Univ Sci; 2021 Dec; 33(8):101637. PubMed ID: 34642560 [TBL] [Abstract][Full Text] [Related]
5. GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 M More-Adate P; Lokhande KB; Swamy KV; Nagar S; Baheti A Comput Biol Med; 2022 Aug; 147():105679. PubMed ID: 35667152 [TBL] [Abstract][Full Text] [Related]
6. A Computational Study of Carbazole Alkaloids from Murraya koenigii as Potential SARS-CoV-2 Main Protease Inhibitors. Wadanambi PM; Jayathilaka N; Seneviratne KN Appl Biochem Biotechnol; 2023 Jan; 195(1):573-596. PubMed ID: 36107386 [TBL] [Abstract][Full Text] [Related]
8. QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods. Chtita S; Belhassan A; Bakhouch M; Taourati AI; Aouidate A; Belaidi S; Moutaabbid M; Belaaouad S; Bouachrine M; Lakhlifi T Chemometr Intell Lab Syst; 2021 Mar; 210():104266. PubMed ID: 33558778 [No Abstract] [Full Text] [Related]
9. Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation. Elekofehinti OO; Iwaloye O; Molehin OR; Famusiwa CD In Silico Pharmacol; 2021; 9(1):49. PubMed ID: 34395160 [TBL] [Abstract][Full Text] [Related]
10. Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis. Liu J; Zhang L; Gao J; Zhang B; Liu X; Yang N; Liu X; Liu X; Cheng Y Front Pharmacol; 2022; 13():961154. PubMed ID: 36091808 [No Abstract] [Full Text] [Related]
11. In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Mengist HM; Khalid Z; Adane F Adv Appl Bioinform Chem; 2023; 16():1-13. PubMed ID: 36699952 [TBL] [Abstract][Full Text] [Related]
12. Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease. Gogoi N; Chowdhury P; Goswami AK; Das A; Chetia D; Gogoi B Mol Divers; 2021 Aug; 25(3):1745-1759. PubMed ID: 33236176 [TBL] [Abstract][Full Text] [Related]